Global Market of Anticoagulants : Research Report till 2031

Visiongain has published a new report on Anticoagulants Market Report to 2031. According to the Visiongain analysis, the global Anticoagulants market is anticipated to grow at a CAGR of XX% during the forecast period (2021-2031). The global anticoagulants market is segmented by type (Vitamin K Antagonists (VKA), Non-VKA Oral Anticoagulants (NOACs), Heparin, others) by Application Atrial fibrillation (Deep vein thrombosis (DVT), Ischemic stroke, Myocardial Infarction (heart attack), Pulmonary embolism, others) by Administration (Oral anticoagulant, Injectable anticoagulant) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed profiles of the leading anticoagulants market companies. PLUS COVID-19 Recovery Scenarios.

Global Anticoagulants Market was valued at US$XX billion in 2020 and is projected to reach a market value of US$ XX billion by 2031

Click here to Get Complete Synopsis of the Report @https://www.visiongain.com/report/anticoagulants-market/

COVID-19 Impact on the Global Anticoagulants Market
The COVID-19 pandemic affected the global anticoagulants market in the first quarter of 2020 due to the strict lockdown and social distancing norms. However, the market gained momentum in the subsequent months owing to unlocking of economies and rising demand for anticoagulants around the globe. In March 2020, The International Society of Thrombosis and Haemostasis (ISTH) introduced guidelines for management of coagulopathy in COVID-19 patients. The prophylactic dose of low-molecular-weight heparin (LMWH) is recommended for COVID-19 patients requiring hospitalization. Additionally, LMWH shows anti-inflammatory properties that enables for setting the elevated cytokines and proinflammatory state of COVID-19 cases.

How the Anticoagulants Market report helps you
In summary, our 240+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Global Anticoagulants Market, with forecasts by type, by application, and by administration, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the global anticoagulants market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa among other prominent economies.

To request a overview of this report please contacts Sara Peerun at sara.peerun@visiongain.com or refer to our website @ https://www.visiongain.com/report/anticoagulants-market/

• Prospects for established firms and those seeking to enter the market– including company profiles for Anticoagulants of the major companies involved in the Anticoagulants Market. Some of the company’s profiled in this report include-
• Abbott Laboratories
• Baxter International Inc.
• AstraZeneca plc
• Bayer AG.
• Boehringer Ingelheim GmbH
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Genentech Inc.
• GlaxoSmithKline plc
• Pfizer, Inc.
• Sanofi S.A
• Novartis AG
• Daiichi Sankyo Company

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Contact:
Address: Airport House, Purley Way, Surrey, London, CR0 0XZ United Kingdom
Name : Sara Peerun
Email: sara.peerun@visiongain.com
Phone: +44(0)2075499987
Research Insight: https://www.visiongain.com/report/anticoagulants-market/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent market research company in London, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide. With the help of an interactive market intelligence platform, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

This release was published on openPR.